000 03589nam a22004695i 4500
001 978-1-4614-0875-8
003 DE-He213
005 20140220083240.0
007 cr nn 008mamaa
008 111107s2012 xxu| s |||| 0|eng d
020 _a9781461408758
_9978-1-4614-0875-8
024 7 _a10.1007/978-1-4614-0875-8
_2doi
050 4 _aRC1-1245
072 7 _aMJ
_2bicssc
072 7 _aMED045000
_2bisacsh
082 0 4 _a616
_223
100 1 _aBraunstein, Glenn D.
_eeditor.
245 1 0 _aThyroid Cancer
_h[electronic resource] /
_cedited by Glenn D. Braunstein.
250 _a1.
264 1 _aBoston, MA :
_bSpringer US :
_bImprint: Springer,
_c2012.
300 _aX, 322 p. 135 illus., 111 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aEndocrine Updates,
_x1566-0729 ;
_v30
505 0 _aPreface -- Contributors -- Pathology and Classification of Thyroid Cancer -- Molecular Biology of Thyroid Cancer -- Thyroid Nodules -- Ultrasound Imaging and Thyroid Cancer -- Fine Needle Aspiration of the Thyroid -- Thyroid Cancer Staging -- Papillary Thyroid Carcinoma -- Follicular Thyroid Carcinoma -- Medullary Thyroid Carcinoma -- Anaplastic Thyroid Carcinoma -- Thyroid Lymphoma -- Surgical Management of Thyroid Cancer -- Radioactive Iodine Therapy -- External Beam Radiation Therapy in the Treatment of Differentiated Thyroid Cancers -- Targeted Therapies of Thyroid Cancer.
520 _aThe American Cancer Society recently estimated that about 45,000 new cases of thyroid cancer will be diagnosed in the United States, with three-quarters occurring in women.  The overall 5-year survival rate is about 97%, making it one of the least lethal cancers.  We are experiencing an epidemic of well-differentiated thyroid cancer, in part due to the widespread use of imaging modalities that detect thyroid nodules and microcarcinomas. Concurrently, there have been a number of recent advances in surgical treatment, as well as diagnostic modalities that allow us to detect small amounts of residual local and metastatic disease. Additionally, a reexamination of past treatment regimens has led to new recommendations regarding the use of radioactive iodine, and to new therapeutic options, such as targeted therapy which have supplanted the use of more toxic chemotherapy for metastatic cancer.  Multiple academic organizations have developed consensus guidelines for the management of thyroid cancer, occasionally with conflicting recommendations. In  Thyroid Cancer, a renowned group of authors presents  a broad overview of the pathology, pathophysiology, diagnosis, and management of thyroid cancer, with an emphasis on recent evidence-based information. State-of-the-art and a significant contribution to the literature, Thyroid Cancer is an invaluable reference for endocrinologists, oncologists, nuclear medicine physicians, radiation oncologists, primary care physicians, and surgeons who deal with head and neck cancer.
650 0 _aMedicine.
650 0 _aInternal medicine.
650 0 _aOncology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aInternal Medicine.
650 2 4 _aOncology.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781461408741
830 0 _aEndocrine Updates,
_x1566-0729 ;
_v30
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4614-0875-8
912 _aZDB-2-SME
999 _c100940
_d100940